Eversept Partners’s Summit Therapeutics SMMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$8.91M Buy
+526,646
New +$7.88M 0.48% 44

Other funds holding SMMT

Eversept Partners's SMMT Position: Q3 2026 in Review

Eversept Partners opened a new position in Summit Therapeutics (SMMT) in Q3 2026: 526,646 shares worth $8.91M. The stake represents 0.48% of the portfolio and ranks #44 among its holdings.

298 funds tracked by Wall St. Rank hold SMMT as of Q3 2026.

  • Eversept Partners held 526,646 shares of Summit Therapeutics worth $8.91M as of Q3 2026.
  • Summit Therapeutics was a new Eversept Partners position in Q3 2026.
  • Summit Therapeutics made up 0.48% of Eversept Partners's portfolio in Q3 2026, its #44 holding.
  • 298 funds tracked by Wall St. Rank held Summit Therapeutics as of Q3 2026.

Based on Eversept Partners's 13F filing for Q3 2026, filed 16 Nov 2026.